FDA Biologics (BLA & Biosimilars)Original article
2022 Center for Biologics Evaluation and Research (CBER) Science Symposium - 09/20/2022
ConferenceNeutral
AI Analysis
Summary
The FDA's Center for Biologics Evaluation and Research (CBER) held a public science symposium to discuss regulatory topics and scientific research on biologics, featuring presentations from academic, government, and research institution experts.
Importance:2/10
Sentiment:
0.00
CBERFDAsymposiumbiologicsregulationscientific conference
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 9, 2026 8:55 PM